|
2026-05-28 |
2026-05-27 |
B
Compra
|
Consejero no ejecutivo
|
2 815
-43.2%
351,75
3.414.053 US$
|
2 815
-43.2%
|
351,75
|
3.414.053 US$
|
|
|
2026-05-28 |
2026-05-26 |
B
Compra
|
Consejero no ejecutivo
|
49 456
-48.4%
59,28
2.417.541 US$
|
49 456
-48.4%
|
59,28
|
2.417.541 US$
|
|
|
2026-05-28 |
2026-05-22 |
B
Compra
|
Consejero no ejecutivo
|
9 918
-17.5%
24,73
1.270.026 US$
|
9 918
-17.5%
|
24,73
|
1.270.026 US$
|
|
|
2026-05-28 |
2026-05-21 |
B
Compra
|
Consejero no ejecutivo
|
3 420
+22.1%
1,04
3.564 US$
|
3 420
+22.1%
|
1,04
|
3.564 US$
|
|
|
2026-05-13 |
2026-04-30 |
B
Compra
|
See Remarks
Consejero ejecutivo
|
25 000
+1221.9%
1,00
25.000 US$
|
25 000
+1221.9%
|
1,00
|
25.000 US$
|
|
|
2025-11-18 |
2025-11-14 |
B
Compra
|
Gran accionista
|
104 183
+12.7%
1,22
127.593 US$
|
104 183
+12.7%
|
1,22
|
127.593 US$
|
|
|
2025-10-28 |
2025-10-28 |
B
Compra
|
Gran accionista
|
178 392
+55.5%
1,39
247.965 US$
|
178 392
+55.5%
|
1,39
|
247.965 US$
|
|
|
2025-10-28 |
2025-10-27 |
B
Compra
|
Gran accionista
|
4 840
+1.5%
1,37
6.625 US$
|
4 840
+1.5%
|
1,37
|
6.625 US$
|
|
|
2025-10-28 |
2025-10-27 |
B
Compra
|
Gran accionista
|
92 642
+12.7%
1,37
126.920 US$
|
92 642
+12.7%
|
1,37
|
126.920 US$
|
|
|
2025-10-28 |
2025-10-24 |
B
Compra
|
Gran accionista
|
30 176
+4.3%
1,39
41.957 US$
|
30 176
+4.3%
|
1,39
|
41.957 US$
|
|
|
2024-12-09 |
2024-12-05 |
B
Compra
|
President and CEO
Oficial
|
161
+inf%
2,25
362 US$
|
161
+inf%
|
2,25
|
362 US$
|
|
|
2024-12-09 |
2024-12-05 |
B
Compra
|
President and CEO
Oficial
|
239
+inf%
2,24
535 US$
|
239
+inf%
|
2,24
|
535 US$
|
|
|
2024-06-17 |
2024-06-17 |
S
Venta
|
Gran accionista
|
4 707
-0.3%
3,25
15.298 US$
|
4 707
-0.3%
|
3,25
|
15.298 US$
|
|
|
2024-06-17 |
2024-06-14 |
S
Venta
|
Gran accionista
|
1 900
-0.1%
3,30
6.270 US$
|
1 900
-0.1%
|
3,30
|
6.270 US$
|
|
|
2024-06-12 |
2024-06-12 |
S
Venta
|
Gran accionista
|
1
-0.0%
3,28
3 US$
|
1
-0.0%
|
3,28
|
3 US$
|
|
|
2024-06-12 |
2024-06-12 |
S
Venta
|
Gran accionista
|
9 341
-0.5%
3,25
30.358 US$
|
9 341
-0.5%
|
3,25
|
30.358 US$
|
|
|
2024-06-12 |
2024-06-11 |
S
Venta
|
Gran accionista
|
502
-0.0%
3,35
1.682 US$
|
502
-0.0%
|
3,35
|
1.682 US$
|
|
|
2024-06-12 |
2024-06-11 |
S
Venta
|
Gran accionista
|
5 250
-0.3%
3,25
17.062 US$
|
5 250
-0.3%
|
3,25
|
17.062 US$
|
|
|
2024-06-12 |
2024-06-10 |
S
Venta
|
Gran accionista
|
9 577
-0.5%
3,30
31.604 US$
|
9 577
-0.5%
|
3,30
|
31.604 US$
|
|
|
2024-06-07 |
2024-06-07 |
S
Venta
|
Gran accionista
|
176
-0.0%
3,30
581 US$
|
176
-0.0%
|
3,30
|
581 US$
|
|
|
2024-06-07 |
2024-06-07 |
S
Venta
|
Gran accionista
|
1 564
-0.1%
3,25
5.083 US$
|
1 564
-0.1%
|
3,25
|
5.083 US$
|
|
|
2024-06-07 |
2024-06-06 |
S
Venta
|
Gran accionista
|
3 184
-0.2%
3,30
10.507 US$
|
3 184
-0.2%
|
3,30
|
10.507 US$
|
|
|
2024-06-07 |
2024-06-06 |
S
Venta
|
Gran accionista
|
1 100
-0.1%
3,27
3.597 US$
|
1 100
-0.1%
|
3,27
|
3.597 US$
|
|
|
2024-06-07 |
2024-06-05 |
S
Venta
|
Gran accionista
|
6 291
-0.4%
3,30
20.760 US$
|
6 291
-0.4%
|
3,30
|
20.760 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
25
-0.0%
4,32
108 US$
|
25
-0.0%
|
4,32
|
108 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
2 903
-0.2%
4,29
12.454 US$
|
2 903
-0.2%
|
4,29
|
12.454 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
200
-0.0%
4,29
857 US$
|
200
-0.0%
|
4,29
|
857 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
337
-0.0%
4,28
1.442 US$
|
337
-0.0%
|
4,28
|
1.442 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
200
-0.0%
4,28
855 US$
|
200
-0.0%
|
4,28
|
855 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
100
-0.0%
4,27
427 US$
|
100
-0.0%
|
4,27
|
427 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
317
-0.0%
4,27
1.352 US$
|
317
-0.0%
|
4,27
|
1.352 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
310
-0.0%
4,26
1.321 US$
|
310
-0.0%
|
4,26
|
1.321 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
7 923
-0.4%
4,25
33.673 US$
|
7 923
-0.4%
|
4,25
|
33.673 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
400
-0.0%
4,18
1.672 US$
|
400
-0.0%
|
4,18
|
1.672 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
670
-0.0%
4,15
2.781 US$
|
670
-0.0%
|
4,15
|
2.781 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
1 600
-0.1%
4,15
6.632 US$
|
1 600
-0.1%
|
4,15
|
6.632 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
380
-0.0%
4,13
1.569 US$
|
380
-0.0%
|
4,13
|
1.569 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
1 750
-0.1%
4,12
7.210 US$
|
1 750
-0.1%
|
4,12
|
7.210 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
100
-0.0%
4,11
411 US$
|
100
-0.0%
|
4,11
|
411 US$
|
|
|
2024-05-01 |
2024-05-01 |
S
Venta
|
Gran accionista
|
3 100
-0.2%
4,10
12.710 US$
|
3 100
-0.2%
|
4,10
|
12.710 US$
|
|
|
2024-05-01 |
2024-04-30 |
S
Venta
|
Gran accionista
|
45
-0.0%
5,00
225 US$
|
45
-0.0%
|
5,00
|
225 US$
|
|
|
2024-05-01 |
2024-04-30 |
S
Venta
|
Gran accionista
|
45
-0.0%
4,95
223 US$
|
45
-0.0%
|
4,95
|
223 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
448
-0.0%
5,03
2.251 US$
|
448
-0.0%
|
5,03
|
2.251 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
13
-0.0%
5,01
65 US$
|
13
-0.0%
|
5,01
|
65 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
3 231
-0.2%
5,00
16.155 US$
|
3 231
-0.2%
|
5,00
|
16.155 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
100
-0.0%
4,94
494 US$
|
100
-0.0%
|
4,94
|
494 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
274
-0.0%
4,93
1.351 US$
|
274
-0.0%
|
4,93
|
1.351 US$
|
|
|
2024-05-01 |
2024-04-29 |
S
Venta
|
Gran accionista
|
6 680
-0.4%
4,92
32.866 US$
|
6 680
-0.4%
|
4,92
|
32.866 US$
|
|
|
2024-04-29 |
2024-04-29 |
PrS
Venta propuesta
|
10% Stockholder
Gran accionista
|
723 984
5,00
3.619.920 US$
|
723 984
|
5,00
|
3.619.920 US$
|
|
|
2023-12-18 |
2023-12-15 |
B
Compra
|
President and COO
Oficial
|
225
+inf%
3,37
758 US$
|
225
+inf%
|
3,37
|
758 US$
|
|
|
2023-11-21 |
2023-11-20 |
B
Compra
|
President and COO
Oficial
|
5 076
+11034.8%
1,97
9.987 US$
|
5 076
+11034.8%
|
1,97
|
9.987 US$
|
|
|
2021-01-08 |
2021-01-08 |
B
Compra
|
See Remarks
Consejero ejecutivo
|
9 000 000
+118.3%
1,10
9.900.000 US$
|
9 000 000
+118.3%
|
1,10
|
9.900.000 US$
|
|
|
2020-06-17 |
2020-06-15 |
B
Compra
|
Consejero no ejecutivo
|
5 800
+inf%
1,22
7.076 US$
|
5 800
+inf%
|
1,22
|
7.076 US$
|
|
|
2020-06-09 |
2020-06-08 |
B
Compra
|
See Remarks
Consejero no ejecutivo
Gran accionista
|
3 700 000
+94.6%
1,10
4.070.000 US$
|
3 700 000
+94.6%
|
1,10
|
4.070.000 US$
|
|
|
2020-06-09 |
2020-06-08 |
B
Compra
|
Consejero no ejecutivo
|
227 272
+104.2%
1,10
249.999 US$
|
227 272
+104.2%
|
1,10
|
249.999 US$
|
|
|
2019-11-18 |
2019-11-15 |
B
Compra
|
Bailey Jeffrey Allen
Consejero no ejecutivo
|
39 142
+109.5%
0,51
19.962 US$
|
39 142
+109.5%
|
0,51
|
19.962 US$
|
|
|
2019-11-18 |
2019-11-14 |
B
Compra
|
Bailey Jeffrey Allen
Consejero no ejecutivo
|
15 858
+79.7%
0,51
8.088 US$
|
15 858
+79.7%
|
0,51
|
8.088 US$
|
|
|
2019-11-14 |
2019-11-12 |
B
Compra
|
|
19 894
+inf%
0,53
10.544 US$
|
19 894
+inf%
|
0,53
|
10.544 US$
|
|
|
2019-09-16 |
2019-09-13 |
B
Compra
|
|
25 000
+12.9%
0,97
24.255 US$
|
25 000
+12.9%
|
0,97
|
24.255 US$
|
|
|
2019-09-16 |
2019-09-12 |
B
Compra
|
|
88 145
+83.9%
0,98
86.250 US$
|
88 145
+83.9%
|
0,98
|
86.250 US$
|
|
|
2019-09-05 |
2019-09-04 |
B
Compra
|
|
23 225
+28.4%
0,71
16.583 US$
|
23 225
+28.4%
|
0,71
|
16.583 US$
|
|
|
2019-09-04 |
2019-09-03 |
B
Compra
|
|
13 466
+19.7%
0,70
9.428 US$
|
13 466
+19.7%
|
0,70
|
9.428 US$
|
|
|
2019-09-04 |
2019-08-30 |
B
Compra
|
|
15 000
+28.1%
0,73
10.968 US$
|
15 000
+28.1%
|
0,73
|
10.968 US$
|
|
|
2019-09-03 |
2019-08-29 |
B
Compra
|
|
3 600
+7.2%
0,77
2.771 US$
|
3 600
+7.2%
|
0,77
|
2.771 US$
|
|
|
2019-08-20 |
2019-08-16 |
B
Compra
|
Vukovic Vojo
SVP, Chief Medical Officer
Oficial
|
75 000
+inf%
0,59
44.452 US$
|
75 000
+inf%
|
0,59
|
44.452 US$
|
|
|
2019-08-15 |
2019-08-13 |
B
Compra
|
Gregory Kathryn
SVP, Chief Business Officer
Oficial
|
45 000
+inf%
0,65
29.025 US$
|
45 000
+inf%
|
0,65
|
29.025 US$
|
|
|
2019-04-02 |
2019-04-01 |
S
Venta
|
Gran accionista
|
20 610
-1.0%
1,90
39.159 US$
|
20 610
-1.0%
|
1,90
|
39.159 US$
|
|
|
2019-04-02 |
2019-03-29 |
S
Venta
|
Gran accionista
|
106 540
-4.8%
1,85
197.099 US$
|
106 540
-4.8%
|
1,85
|
197.099 US$
|
|
|
2019-03-15 |
2019-03-15 |
S
Venta
|
Gran accionista
|
43 800
-1.9%
1,92
84.096 US$
|
43 800
-1.9%
|
1,92
|
84.096 US$
|
|
|
2019-03-15 |
2019-03-14 |
S
Venta
|
Gran accionista
|
13 800
-0.6%
1,88
25.944 US$
|
13 800
-0.6%
|
1,88
|
25.944 US$
|
|
|
2019-03-15 |
2019-03-13 |
S
Venta
|
Gran accionista
|
132 738
-5.5%
2,12
281.405 US$
|
132 738
-5.5%
|
2,12
|
281.405 US$
|
|
|
2018-08-22 |
2018-08-20 |
S
Venta
|
Novartis Bioventures Ltd
Gran accionista
|
20 388
-0.8%
2,30
46.892 US$
|
20 388
-0.8%
|
2,30
|
46.892 US$
|
|
|
2018-08-20 |
2018-08-17 |
S
Venta
|
Novartis Bioventures Ltd
Gran accionista
|
8 700
-0.4%
2,10
18.270 US$
|
8 700
-0.4%
|
2,10
|
18.270 US$
|
|
|
2018-08-20 |
2018-08-16 |
S
Venta
|
Novartis Bioventures Ltd
Gran accionista
|
8 808
-0.4%
2,10
18.497 US$
|
8 808
-0.4%
|
2,10
|
18.497 US$
|
|
|
2018-08-16 |
2018-08-15 |
S
Venta
|
Novartis Bioventures Ltd
Gran accionista
|
2 635
-0.1%
2,15
5.665 US$
|
2 635
-0.1%
|
2,15
|
5.665 US$
|
|